Ingenuity Systems, the California, US-based life sciences software developer has announced a research collaboration with US contract research organisation (CRO), Covance.
Takeda Pharmaceuticals has joined the growing list of pharma companies to forge strategic deals with contract research organisations (CRO) by signing new deals with Covance and Quintiles.
Big pharma outsourcing will become much bolder in the next 12-18 months as companies attempt to “dramatically attack cost structures”, according to the Covance CEO.
Outsourcing-Pharma presents a round up five of our top articles on strategic partnering, which continued apace in 2010, including deals by Covance, PPD and Parexel.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including the departure of Patheon’s CEO and a number of promotions at Covance.
Covance has added a 40,000 sq ft biotech laboratory to its site in Indiana, US site to support its relationship with Eli Lilly and boost capacity outside Europe.
Covance has established a Discovery and Translational Services unit, integrating a number of existing operations, to foster greater scientific and technical collaboration.
The CRO results season is underway with Icon and Covance both posting mixed Q3 figures as the challenges facing pharma, and businesses in general, continue to impact on operations.
Covance says its new clinical development offices in Brazil and Mexico will increase access to treatment-naïve patients and, ultimately, save pharmaceutical sponsors money.
US CRO Covance has delayed the construction of a proposed $145m (€102m) preclinical toxicology testing facility at a 47 acre site at the Prince William Technology Park in Virginia.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at Covance, Sundia MediTech and Cardinal.
Charles River Laboratories (CRL) has bucked the CRO sector trend and reaffirmed its forecasts for 2009, citing an improved order book and better pricing as the reasons for its relative optimism.
The past few days have seen a string of announcements from contract research organisations (CROs) which indicate that their appetite for international expansion and development remains unsated.
Covance has expanded its clinical pharmacology capabilities via the purchase of Swiss Pharma Contract, a 50-bed clinical research company based in Basel.
The world’s largest contract research organisation, Covance, has maintained its earnings guidance for 2009 despite a slowdown in revenue growth and lower profits in the fourth quarter of 2008.
Contract research firm Covance has been given the green light for its $100m (€77m) animal testing and drug candidate development facility in Chandler, Arizona, US.
Covance has defied challenging market conditions and posted positive results for the third quarter, with the company believing more major R&D outsourcing contracts are a possibility.
Eli Lilly took a giant leap down the outsourcing road yesterday with the sale of a major R&D facility to contract research organisation Covance and the forging of additional agreement with Quintiles and i3.
US contract research giant Covance saw a strong performance across its divisions in the second quarter that lifted its revenues by 15 per cent to $462m.
Covance is again at the centre of controversy as opponents of the contract research organisation (CRO) filed a lawsuit against a city in Arizona, aimed at stopping the firm from building a new drug-testing facility there.
This week Covance has paid PETA Europe's court costs relating back
to a failed legal bid to prevent the broadcast of video footage
taken during a covert investigation of its US animal laboratory.
Meanwhile, GSK has had a positive...
The mayor of a US city where Covance is planning to build a
controversial new preclinical testing facility met last week with
the Food and Drug Administration (FDA) and government officials to
discuss the animal testing issues surrounding...
Covance was nothing but optimistic about the future of contract
research organisations (CROs) during a JPMorgan healthcare
conference held last week, despite a slowdown in R&D spending
over the past year.
World-leading clinical research organisation (CRO) Covance has
scored what it says is the biggest contract in its history - a
dedicated space agreement worth a minimum of $187m (€149m).
Covance has stepped up its laboratory testing capabilities in the
Asia Pacific region to satisfy the growing number of sponsors
conducting clinical studies in this budding location.
A new interactive voice response (IVR) package is available for
small clinical trials, aimed at companies who previously found this
technology unaffordable.
Leading contract research organisation, Covance, has upgraded its
software to streamline the laboratory testing aspect of its
clinical trials and allow sponsoring drug companies greater
involvement in the overall process.